Cargando…

Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate

INTRODUCTION: This study was aimed at characterizing basal and adrenocorticotropic hormone (ACTH)-induced steroidogenesis in sepsis and nonsepsis patients with a suspicion of critical illness-related corticosteroid insufficiency (CIRCI), taking the use of etomidate-inhibiting 11β-hydroxylase into ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Molenaar, Nienke, Bijkerk, Ronald M, Beishuizen, Albertus, Hempen, Christel M, de Jong, Margriet FC, Vermes, Istvan, van der Sluijs Veer, Gertjan, Girbes, Armand RJ, Groeneveld, AB Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580698/
https://www.ncbi.nlm.nih.gov/pubmed/22781364
http://dx.doi.org/10.1186/cc11415
_version_ 1782260310389817344
author Molenaar, Nienke
Bijkerk, Ronald M
Beishuizen, Albertus
Hempen, Christel M
de Jong, Margriet FC
Vermes, Istvan
van der Sluijs Veer, Gertjan
Girbes, Armand RJ
Groeneveld, AB Johan
author_facet Molenaar, Nienke
Bijkerk, Ronald M
Beishuizen, Albertus
Hempen, Christel M
de Jong, Margriet FC
Vermes, Istvan
van der Sluijs Veer, Gertjan
Girbes, Armand RJ
Groeneveld, AB Johan
author_sort Molenaar, Nienke
collection PubMed
description INTRODUCTION: This study was aimed at characterizing basal and adrenocorticotropic hormone (ACTH)-induced steroidogenesis in sepsis and nonsepsis patients with a suspicion of critical illness-related corticosteroid insufficiency (CIRCI), taking the use of etomidate-inhibiting 11β-hydroxylase into account. METHOD: This was a prospective study in a mixed surgical/medical intensive care unit (ICU) of a university hospital. The patients were 62 critically ill patients with a clinical suspicion of CIRCI. The patients underwent a 250-μg ACTH test (n = 67). ACTH, adrenal steroids, substrates, and precursors (modified tandem mass spectrometry) also were measured. Clinical characteristics including use of etomidate to facilitate intubation (n = 14 within 72 hours of ACTH testing) were recorded. RESULTS: At the time of ACTH testing, patients had septic (n = 43) or nonseptic critical illness (n = 24). Baseline cortisol directly related to sepsis and endogenous ACTH, independent of etomidate use. Etomidate was associated with a lower baseline cortisol and cortisol/11β-deoxycortisol ratio as well as higher 11β-deoxycortisol, reflecting greater 11β-hydroxylase inhibition in nonsepsis than in sepsis. Cortisol increases < 250 mM in exogenous ACTH were associated with relatively low baseline (HDL-) cholesterol, and high endogenous ACTH with low cortisol/ACTH ratio, independent of etomidate. Although cortisol increases with exogenous ACTH, levels were lower in sepsis than in nonsepsis patients, and etomidate was associated with diminished increases in cortisol with exogenous ACTH, so that its use increased, albeit nonsignificantly, low cortisol increases to exogenous ACTH from 38% to 57%, in both conditions. CONCLUSIONS: A single dose of etomidate may attenuate stimulated more than basal cortisol synthesis. However, it may only partly contribute, particularly in the stressed sepsis patient, to the adrenal dysfunction of CIRCI, in addition to substrate deficiency.
format Online
Article
Text
id pubmed-3580698
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35806982013-02-26 Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate Molenaar, Nienke Bijkerk, Ronald M Beishuizen, Albertus Hempen, Christel M de Jong, Margriet FC Vermes, Istvan van der Sluijs Veer, Gertjan Girbes, Armand RJ Groeneveld, AB Johan Crit Care Research INTRODUCTION: This study was aimed at characterizing basal and adrenocorticotropic hormone (ACTH)-induced steroidogenesis in sepsis and nonsepsis patients with a suspicion of critical illness-related corticosteroid insufficiency (CIRCI), taking the use of etomidate-inhibiting 11β-hydroxylase into account. METHOD: This was a prospective study in a mixed surgical/medical intensive care unit (ICU) of a university hospital. The patients were 62 critically ill patients with a clinical suspicion of CIRCI. The patients underwent a 250-μg ACTH test (n = 67). ACTH, adrenal steroids, substrates, and precursors (modified tandem mass spectrometry) also were measured. Clinical characteristics including use of etomidate to facilitate intubation (n = 14 within 72 hours of ACTH testing) were recorded. RESULTS: At the time of ACTH testing, patients had septic (n = 43) or nonseptic critical illness (n = 24). Baseline cortisol directly related to sepsis and endogenous ACTH, independent of etomidate use. Etomidate was associated with a lower baseline cortisol and cortisol/11β-deoxycortisol ratio as well as higher 11β-deoxycortisol, reflecting greater 11β-hydroxylase inhibition in nonsepsis than in sepsis. Cortisol increases < 250 mM in exogenous ACTH were associated with relatively low baseline (HDL-) cholesterol, and high endogenous ACTH with low cortisol/ACTH ratio, independent of etomidate. Although cortisol increases with exogenous ACTH, levels were lower in sepsis than in nonsepsis patients, and etomidate was associated with diminished increases in cortisol with exogenous ACTH, so that its use increased, albeit nonsignificantly, low cortisol increases to exogenous ACTH from 38% to 57%, in both conditions. CONCLUSIONS: A single dose of etomidate may attenuate stimulated more than basal cortisol synthesis. However, it may only partly contribute, particularly in the stressed sepsis patient, to the adrenal dysfunction of CIRCI, in addition to substrate deficiency. BioMed Central 2012 2012-07-10 /pmc/articles/PMC3580698/ /pubmed/22781364 http://dx.doi.org/10.1186/cc11415 Text en Copyright ©2012 Molenaar et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Molenaar, Nienke
Bijkerk, Ronald M
Beishuizen, Albertus
Hempen, Christel M
de Jong, Margriet FC
Vermes, Istvan
van der Sluijs Veer, Gertjan
Girbes, Armand RJ
Groeneveld, AB Johan
Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate
title Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate
title_full Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate
title_fullStr Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate
title_full_unstemmed Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate
title_short Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate
title_sort steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580698/
https://www.ncbi.nlm.nih.gov/pubmed/22781364
http://dx.doi.org/10.1186/cc11415
work_keys_str_mv AT molenaarnienke steroidogenesisintheadrenaldysfunctionofcriticalillnessimpactofetomidate
AT bijkerkronaldm steroidogenesisintheadrenaldysfunctionofcriticalillnessimpactofetomidate
AT beishuizenalbertus steroidogenesisintheadrenaldysfunctionofcriticalillnessimpactofetomidate
AT hempenchristelm steroidogenesisintheadrenaldysfunctionofcriticalillnessimpactofetomidate
AT dejongmargrietfc steroidogenesisintheadrenaldysfunctionofcriticalillnessimpactofetomidate
AT vermesistvan steroidogenesisintheadrenaldysfunctionofcriticalillnessimpactofetomidate
AT vandersluijsveergertjan steroidogenesisintheadrenaldysfunctionofcriticalillnessimpactofetomidate
AT girbesarmandrj steroidogenesisintheadrenaldysfunctionofcriticalillnessimpactofetomidate
AT groeneveldabjohan steroidogenesisintheadrenaldysfunctionofcriticalillnessimpactofetomidate